Cynosure Lutronic bolsters its strength in APAC — The world’s fastest-growing medical aesthetics device region, with dual regulatory approvals for the Clarity II™ in China and Japan, February 2026
2026-02-27 - 03:36
SINGAPORE, Feb. 27, 2026 /PRNewswire/ — Cynosure Lutronic, a global leader in energy-based medical aesthetic devices, announced today that Clarity II, its dual-wavelength long-pulse laser platform, has received regulatory approval in China and Japan. This marks a significant expansion of the company’s clinically approved laser portfolio across two of Asia’s most highly regulated aesthetic markets. Clarity II Receives Regulatory Clearance in China and
Share this post: